Patents by Inventor Gregory R. Siragusa

Gregory R. Siragusa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170014516
    Abstract: Compositions and methods are disclosed for providing beneficial effects to animals, such as reducing harmful pathogens and increasing performance. In one embodiment, the composition is a gel that can be applied to a bird to increase performance and reduce pathogens. In yet another embodiment, the composition further comprises one or more direct fed microbial (“DFM”). In still another embodiment, methods are disclosed for treatment of and/or for the prevention of diseases of birds.
    Type: Application
    Filed: September 14, 2015
    Publication date: January 19, 2017
    Applicant: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Lars W. Petersen, Gregory R. Siragusa, Firmin G. Delago, Dennis C. Gainey
  • Patent number: 8962297
    Abstract: The present invention relates to isolated Clostridium perfringens bacteriophage lytic enzymes from baccteriophages CP26F and CP39O, and uses in controlling Clostridium perfringens.
    Type: Grant
    Filed: September 1, 2010
    Date of Patent: February 24, 2015
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Bruce S. Seal, Gregory R. Siragusa, Ibn Mustafa A. Simmons, Johnna K. Garrish, David M. Donovan
  • Publication number: 20150045288
    Abstract: The present invention relates to anti-contaminant composition comprising a cell-free fermentation product of one or more Bacillus subtilis strains (e.g., selected from the group consisting of: 22C-P1, 15A-P4, 3A-P4, LSSA01, ABP278, BS 2084 and BS 18); wherein said fermentation product comprises one or more compounds selected from the group consisting of: a lipopeptide, a polyketide, a bacillibactin, a bacilysin, an anticapsin, a plantazolicin, a LCI, a homologue of a plantazolicin and a homologue of a LCI. In addition, the present invention further relates to methods of preparing the compositions, methods of using the composition, products comprising the composition and uses thereof.
    Type: Application
    Filed: February 20, 2013
    Publication date: February 12, 2015
    Inventors: Tina Mygind, George H. Weber, Connie Benfeldt, Ashley Ann Hibberd, Rebecca Joy Landrum, Panagiotis Chanos, Gregory R. Siragusa, Matthew James Hundt
  • Publication number: 20120052546
    Abstract: The present invention relates to isolated Clostridium perfringens bacteriophage lytic enzymes from baccteriophages CP26F and CP39O, and uses in controlling Clostridium perfringens.
    Type: Application
    Filed: September 1, 2010
    Publication date: March 1, 2012
    Applicant: The United State of America, as represented by the Secretary of Agriculture
    Inventors: Bruce S. Seal, Gregory R. Siragusa, Ibn Mustafa A. Simmons, Johnna K. Garrish, David M. Donovan